NFKB1 and familial pancreatic carcinoma: Our previous study indicated that I3C, PEITC, RES, and X decreased activation of NF-κB and enhanced activation of Nrf2 in pancreatic cancer cells (PANC-1, and Mia-Pa-Ca-1) [24,25].